西玛试剂
电话/微信:18622987668
|
日本JCRB细胞保藏中心(JCRB细胞库)成立于1985年,JCRB保藏中心通过了BS EN ISO 9001:2008认证,提供了近1400多种细胞株和细胞系。JCRB细胞库专注于收集人类和动物的各种培养细胞,包括癌症和转基因细胞。JCRB的细胞资源被分发给日本和世界各地的研究人员。这些细胞经过了充分的微生物污染、病毒污染和交叉培养污染检测,均验证为合格细胞株。一些细胞经过了核型和/或细胞表面标记特征鉴定。JCRB一直致力于开发细胞培养和质量控制的新方法,以支持药物科学的医学基础研究。 JCRB Cell Bank 日本JCRB细胞保藏中心 细胞目录-4 编号 细胞类型 细胞名称 JCRB编号 动物源 组织来源 简介 515 general cells IHH-4 JCRB1079 human lymph node Human papillary thyroid carcinoma cell line metastased to lymphnode. STR-PCR analysis showed the same pattern with the cell line TMH-1. 516 genetically-modified cells IKK-i-DEF JCRB1534 mouse embryo Mouse embryonic fibroblasts prepared from IkB kinase (IKK-i) deficient mice. 517 general cells IM-9 JCRB0024 human bone marrow myeloma, multiple, B lymphoblastic 518 general cells IM-9 IFO50025 human blood IgG-secreting B-lymphoblastic cell line. 519 general cells IM95 JCRB1075.0 human stomach Human gastric cancer cell line. 520 general cells IM95m JCRB1075.1 human stomach Human gastric cancer cell line. 521 general cells IMR-32 JCRB9050 human neuroblastoma arising at abdomen Human neuroblastoma cell line. 522 general cells IMR-32 IFO50283 human Human nueroblastoma cell line. 523 general cells IMR-90 JCRB0516 human lung Normal human fibroblast. 524 general cells IMR-90 JCRB9054 human lung Normal human fibroblast. 525 general cells IMR-90-40 JCRB0519 human lung Normal human fibroblast. 526 general cells IMR-90-50 JCRB0520 human lung Human primary cells. 527 general cells In-1024 JCRB1737 hamster, Syrian pancreas Insulinoma cell line of Syrian hamster induced by BK virus. 528 general cells Indian Muntjac JCRB9100 Indian Muntjak skin Indian muntjak cell line, a primitive deer. 529 general cells Int-3LL JCRB1351 mouse Variant cell line possessing enhanced intravasating ability derived from Lewis lung cancer (3LL). 530 general cells Ishikawa 3-H-12 JCRB1505 human Endometrium Estrogen receptor (ER), progesterone receptor (PR) expressing cell line. 531 general cells IT-26R21 IFO50078 rat thymus T cell differentiation factor producing, (Wistar rat) 532 general cells IT-45R1 IFO50076 rat thymus T cell differentiation factor producing, (Wistar rat) 533 general cells IT-45R91 IFO50077 rat thymus thymic fibroblast, (Wistar rat) 534 general cells IT-79MTNC3 IFO50248 mouse thymus thymic nurse cell, (BALB/c mouse) 535 general cells ITO-II JCRB0613 human testis Human testicular tumor cell line. 536 general cells ITSM JCRB1635 human ascites Human B cell line established from patient diagnosed as pseudomyxoma peritonei. 537 general cells J-111 JCRB0073 human peripheral blood The cell line deposited as a human acute monocytic leukemia but many data show this cell line is a subline of the HeLa. 538 general cells J-111 IFO50005 human blood HeLa markers* 539 general cells J774.1 JCRB0018 mouse ascites monocyte-macrophage, IL-1-producing, (BALB/c mouse) 540 general cells J774A.1 JCRB9108 mouse ascites Mouse macrophage cell line. 541 general cells JHH-2 JCRB1028 human liver Human hepatocellular carcinoma cell line (Ed.II). 542 general cells JHH-4 JCRB0435 human liver Human hepatocellular carcinoma cell line. 543 general cells JHH-5 JCRB1029 human resected liver sample Human hepatocellular carcinoma (Ed.I) established from small liver cancer. 544 general cells JHH-6 JCRB1030 human Human hepatocellular carcinoma cell line. 545 general cells JHH-7 JCRB1031 human liver HBV integrated human hepato cellular carcinoma cell line. 546 general cells JKT-beta-del JCRB0147 human blood The JKT-beta-del cell line isolated from the Jurkat cells{5011} by a cell sorter and lacks the surface expression of the T-cell receptor alpha/beta/CD3 complex. 547 general cells JMU-RTK-2 JCRB1484 human Kidney Malignant rhabdoid tumor of the kidney cell line. 548 general cells JTC-11 JCRB0424 mouse ascites In vitro adapted strain of Ehrlich ascites carcinoma. 549 general cells JTC-16 P3 JCRB0714 rat ascites Serum free rat ascites hepatoma cell line. 550 general cells JTC19 JCRB0608 rat lung lung, (JAR-1 rat) 551 general cells K562 JCRB0019 human pleural effusion Highly undifferentiated and granurocytic myelogenous leukemia cell line from blast crisis. 552 general cells K562/ADM JCRB1002 human pleural effusion Adriamycine resistant derivative of K562 cell line. 553 general cells KAI3 IFO50518 human peripheral blood EBV-infected NK-like cell line, IL-2 dependent 554 general cells KALS-1 IFO50434 human brain GFAP is weakly positive. 555 general cells Kasumi-1 JCRB1003 human blood A novel leukemia cell line with an t8;21 chromosome translocation established from a patient attaked by acute myeloid leukemia(AML). 556 general cells Kasumi-10 JCRB1410 human blood B cell leukemia 557 general cells Kasumi-2 JCRB1395 human blood B cell precursor leukemia 558 general cells Kasumi-3 JCRB1004 human blood A novel human leukemia cell line established from blast cells of a patient attaked by myeloperoxidase-negative acute leukemia. 559 general cells Kasumi-4 JCRB0161 human blood A novel human leukemia cell line established from a patient with chronic myelogenous leukaemia (CML) in blast crisis. 560 general cells Kasumi-5 JCRB1398 human blood T cell leukemia 561 general cells Kasumi-6 JCRB1024 human peripheral blood Human acute myeloid leukemia cell line with dominant negative mutation in the C/EBP alpha gene. 562 general cells Kasumi-7 JCRB1401 human blood B cell leukemia 563 general cells Kasumi-8 JCRB1403 human blood B cell leulemia 564 general cells Kasumi-9 JCRB1409 human blood B cell leukemia 565 general cells KasumiA-541 JCRB1411 human blood mixed lineage leukemia 566 general cells KasumiA-554 JCRB1416 human blood myeloid leukemia secondary to ATL 567 general cells KasumiA-568 JCRB1415 human blood myeloblastic leukemia 568 general cells KATOIII JCRB0611 human stomach signet ring cell carcinoma 569 general cells KB JCRB9027 human oral The cell line KB has been known that this cell line is a subline of the HeLa. 570 general cells KCL-22 JCRB1317 human pleural effusion Human myeloid cell line from chronic myelocytic leukemia. 571 general cells KCMC-1379 JCRB1511 human skin Human fibroblast cells derived from Beare-Stevenson syndrome patient. 572 general cells KCMC-1528 JCRB1541 human 573 general cells KCMC-1694 JCRB1540 human skin 574 general cells KD JCRB9103 human lip fibroblast, lip 575 general cells KE-3 JCRB1883 human esophagus Human moderately differentiated squamous cell carcinoma cell line established from esophageal cancer. 576 general cells KE-4 JCRB1887 human esophaqus Human poorly differentiated squamous cell carcinoma cell line established from esophageal cancer. 577 general cells KG-1 JCRB0065 human bone marrow leukemia, acute myeloblastic 578 general cells KG-1 JCRB9051 human bone marrow leukemia, acute myelogenous 579 general cells KG-1-C JCRB0236 human brain mixed glioma, GFAP-negative, S-100-positive (growth is very slow). 580 general cells KHM-10B JCRB0165 human peripheral blood Human Bukitt's lymphoma, ALL-L3 cell line. HLA-DR,CD19 and surface immunoglobulin(mu, lambda) positive. Ig gene rearrangements observed. 581 general cells KHM-1B JCRB0133 human pleural effusion myeloma, multiple, with hyperamylasemia. 582 general cells KHM-2B JCRB1394 human Peripheral blood Human acute B-cell lymphocytic leukemia cell line with two translocations t(8;14) and t(14;18). 583 general cells KHM-3S JCRB0138 human pleural effusion small cell carcinoma, HTLV-1gene integration 584 general cells KHM-5M JCRB0148 human pleural effusion Undifferentiated human thyroid cell line producing interl eukin 8. 585 general cells KHYG-1 JCRB0156 human peripheral blood Human natural killer cell line with a p53 point mutation as a model for p53-associated leukemogenesis and a model for differentiation of NK/T cells. 586 general cells Ki-JK JCRB1065 human pleural fluid Human mononuclear cells with multiple nucleoli from lymphoma patient. 587 general cells KIK4 JCRB1725 human Human fibroblast cell Line with mutation of LDL receptor 588 general cells KINGS-1 IFO50435 human brain astrocytoma, anaplastic, S-100, vimentin, CD13 and HNK-1-positive, weakly GFAP positive. 589 general cells KKK-D049 JCRB1771 human intrahepatic bile duct Human well differentiated tubular adenocarcinoma cell line established from biliary tract. 590 general cells KKK-D068 JCRB1775 human Intrahepatic bile duct Human well differentiated tubular adenocarcinma cell line established from biliary tract. (with micropapillary foci) 591 general cells KKK-D131 JCRB1777 human intrahepatic bile duct Human well differentiated tubular adenocarcinoma cell line established from biliary tract. 592 general cells KKK-D138 JCRB1779 human intrahepatic bile duct Human adenosquamous carcinoma cell line established from biliary tract. 593 general cells KKU-023 JCRB1778 human Human well differentiated cholangiocarcinoma cell line established from biliary tract. 594 general cells KKU-055 JCRB1551 human biliary tract Human poorly differentiated cholangiocarcinoma cell line established from biliary tract. 595 general cells KKU-100 JCRB1568 human biliary tract Human poorly differentiated cholangiocarcinoma cell line established from biliary tract. 596 general cells KKU-213 JCRB1557 human biliary tract Human mixed (papillary and non-papillary) cholangiocarcinoma cell line established from biliary tract. 597 general cells KKU-452 JCRB1772 human Human poorly differentiated cholangiocarcinoma cell line established from biliary tract. 598 general cells KM8 JCRB1713 human skin Human fibroblast cell Line with mutation of LDL receptor 599 general cells KMBC-2 JCRB1148 human urinary bladder Urinary bladder cancer cell line 600 general cells KMH-2 JCRB1066 human cervical tumor Human anaplasitc thyroid carcinoma cell line with multidrug resistance, derived from a left cervical tumor with a sligt leukocytosis. 601 general cells KML-1 JCRB1347 human pleural effusion Human B-cell lymphoma cell line. 602 general cells KMLS-1 JCRB0200 human liposarcoma 603 general cells KMM-1 JCRB1180 human subcutaneous tumor human myeloma cell line 604 general cells KMP2 JCRB1427 human liver metastasis Human moderately differentiated pancreatic adenocarcinoma cell line established from liver metastasis. 605 general cells KMP3 JCRB1440 human liver metastasis Human moderately differentiated adenocarcinoma cell line established from pancreas cancer. 606 general cells KMP5 JCRB1464 human liver metastasis Human moderately differentiated adenocarcinoma cell line established from liver metastasis. 607 general cells KMP7 JCRB1429 human liver metastasis Human pancreatic adenocarcinoma cell line established from liver metastasis. 608 general cells KMP8 JCRB1461 human liver metastasis Human moderately differentiated pancreatic adenocarcinoma cell line established from liver metastasis. 609 general cells KMPC-3 JCRB1150 human right renal pelvis Human renal pelvis. 610 general cells KMRC-1 JCRB1010 human kidney Human tumor cell line from kidney. Clear cell renal carcinoma cell line. 611 general cells KMRC-2 JCRB1011 human kidney Human tumor cell line from kidney. Clear cell renal carcinoma cell line. 612 general cells KMRC-20 JCRB1071 human kidney Human renal carcinoma cell line from kidney. 613 general cells KMRC-3 JCRB1012 human kidney Human tumor cell line from kidney. Clear cell renal carcinoma cell line. 614 general cells KMRM-M1 JCRB1014 human muscle Human renal cancer cell line metastasized to muscle. 615 general cells KMS-11 JCRB1179 human pleural effusion human myeloma cell line. 616 general cells KMS-11/BTZ JCRB1642 human pleural effusion bortezomib-resistant maultiple myeloma cell line. 617 general cells KMS-12-BM JCRB0429 human bone marrow myeloma, late stage of B-cell differentiation 618 general cells KMS-12-PE JCRB0430 human pleural effusion myeloma, late stage of B-cell differentiation 619 general cells KMS-20 JCRB1196 human bone marrow human myeloma cell line. 620 general cells KMS-21BM JCRB1185 human bone marrow human myeloma cell line. 621 general cells KMS-24 JCRB1184 human bone marrow Stop providing for the issue of quality control. (Please contact us for more information) human myeloma cell line. 622 general cells KMS-26 JCRB1187 human pleural effusion human myeloma cell line. 623 general cells KMS-27 JCRB1188 human peripheral blood human myeloma cell line. 624 general cells KMS-28BM JCRB1192 human bone marrow human myeloma cell line. 625 general cells KMS-28PE JCRB1191 human pleural effusion Human myeloma cell line. 626 general cells KMS-33 JCRB1391 human bone marrow human myeloma cell line. 627 general cells KMS-34 JCRB1195 human pleural effusion human myeloma cell line. 628 general cells KMS-6 JCRB0432 human embryo fibroblast, normal diploid 629 general cells KMST-6 JCRB0433 human embryo fibroblast, immortalized by 60Co irradiation, derivative of KMS-6 630 general cells KNS-42 IFO50356 human brain glioma, GFAP-positive, S-100 and NSE-negative |